<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>Future Lipidology via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Future Lipidology' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Future+Lipidology&t=Future+Lipidology&s=Search&f=source]]></link>
        <lastBuildDate>Sat, 10 Oct 2009 19:31:30 +0100</lastBuildDate>
        <item>
            <title>Therapeutic potential of phosphoethanolamine-bound C-reactive protein in atherosclerosis</title>
            <link>http://www.medworm.com/index.php?rid=1997075&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.6.599%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , December 2008, Vol. 3, No. 6, Pages 599-602. (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1997075</comments>
            <pubDate>Fri, 28 Nov 2008 14:30:50 +0100</pubDate>
            <guid isPermaLink="false">1997075</guid>        </item>
        <item>
            <title>Biology of LOX-1 in relation to atherogenesis</title>
            <link>http://www.medworm.com/index.php?rid=1997084&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.6.689%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , December 2008, Vol. 3, No. 6, Pages 689-696. 
		
	LOX-1, a lectin-like 52 kD receptor for oxidized LDL, is present primarily on endothelial cells. It has been linked to endothelial dysfunction, inflammation and oxidative stress. LOX-1 activation has also been linked to collagen formation, a key component ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1997084</comments>
            <pubDate>Fri, 28 Nov 2008 13:50:24 +0100</pubDate>
            <guid isPermaLink="false">1997084</guid>        </item>
        <item>
            <title>Sphingosine-1-phosphate synthesis and functions in mast cells</title>
            <link>http://www.medworm.com/index.php?rid=1997082&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.6.665%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , December 2008, Vol. 3, No. 6, Pages 665-674. 
		
	Sphingolipids are not only major lipid components of all eukaryotic cell membranes, but they also comprise an important family of bioactive signaling molecules that regulate a diverse array of biological responses. The sphingolipid metabolite sphingosine-... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1997082</comments>
            <pubDate>Fri, 28 Nov 2008 13:50:22 +0100</pubDate>
            <guid isPermaLink="false">1997082</guid>        </item>
        <item>
            <title>Augmentation of the renin–angiotensin system by hypercholesterolemia promotes vascular diseases</title>
            <link>http://www.medworm.com/index.php?rid=1997079&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.6.625%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , December 2008, Vol. 3, No. 6, Pages 625-636. 
		
	Activation of the renin–angiotensin system (RAS) and aberrant cholesterol metabolism have generally been considered as independent mechanisms in the development of several vascular diseases. However, it is becoming increasingly apparent in both human and ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1997079</comments>
            <pubDate>Fri, 28 Nov 2008 13:50:22 +0100</pubDate>
            <guid isPermaLink="false">1997079</guid>        </item>
        <item>
            <title>Bulletin Board</title>
            <link>http://www.medworm.com/index.php?rid=1997077&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.6.607%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , December 2008, Vol. 3, No. 6, Pages 607-609. (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1997077</comments>
            <pubDate>Fri, 28 Nov 2008 13:50:21 +0100</pubDate>
            <guid isPermaLink="false">1997077</guid>        </item>
        <item>
            <title>Sex hormones and circulating lipoprotein levels</title>
            <link>http://www.medworm.com/index.php?rid=1997076&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.6.603%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , December 2008, Vol. 3, No. 6, Pages 603-606. (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1997076</comments>
            <pubDate>Fri, 28 Nov 2008 13:50:21 +0100</pubDate>
            <guid isPermaLink="false">1997076</guid>        </item>
        <item>
            <title>Acknowledgements</title>
            <link>http://www.medworm.com/index.php?rid=1997086&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.6.709%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , December 2008, Vol. 3, No. 6, Pages 709-709. (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1997086</comments>
            <pubDate>Fri, 28 Nov 2008 13:50:20 +0100</pubDate>
            <guid isPermaLink="false">1997086</guid>        </item>
        <item>
            <title>Oxidized LDL and the metabolic syndrome</title>
            <link>http://www.medworm.com/index.php?rid=1997080&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.6.637%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , December 2008, Vol. 3, No. 6, Pages 637-649. 
		
	The metabolic syndrome is a common and complex disorder combining obesity, dyslipidemia, hypertension and insulin resistance. It is associated with a high cardiovascular risk that can only partially be explained by its components. There is evidence that ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1997080</comments>
            <pubDate>Fri, 28 Nov 2008 13:50:19 +0100</pubDate>
            <guid isPermaLink="false">1997080</guid>        </item>
        <item>
            <title>Lipidology: bridge between basic science and clinical pathology</title>
            <link>http://www.medworm.com/index.php?rid=1997078&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.6.611%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , December 2008, Vol. 3, No. 6, Pages 611-623. 
		
	The 49th meeting of the International Conference for the Bioscience of Lipids (ICBL) was convened at the end of August 2008 in the historic city of Maastricht in The Netherlands. The meeting organizers (Jan Glatz, Joost Luiken and Edouard Bevers) crafted ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1997078</comments>
            <pubDate>Fri, 28 Nov 2008 13:50:16 +0100</pubDate>
            <guid isPermaLink="false">1997078</guid>        </item>
        <item>
            <title>Uncontrolled airway inflammation in lung disease represents a defect in counter-regulatory signaling</title>
            <link>http://www.medworm.com/index.php?rid=1997085&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.6.697%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , December 2008, Vol. 3, No. 6, Pages 697-704. 
		
	Counter-regulatory lipid mediators are generated during airway inflammation to promote resolution. Defects in the production of these lipid mediators have now been associated with several diseases of persistent airway inflammation. Lipoxins are the lead ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1997085</comments>
            <pubDate>Fri, 28 Nov 2008 13:50:15 +0100</pubDate>
            <guid isPermaLink="false">1997085</guid>        </item>
        <item>
            <title>Insulin resistance and lipid disorders</title>
            <link>http://www.medworm.com/index.php?rid=1997081&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.6.651%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , December 2008, Vol. 3, No. 6, Pages 651-664. 
		
	The dyslipidemia of insulin resistance is characterized by elevated levels of triglycerides (TGs), low HDL-cholesterol and small dense LDL particles. Many of these features are affected by the reduction in insulin sensitivity, with a central role played ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1997081</comments>
            <pubDate>Fri, 28 Nov 2008 13:50:14 +0100</pubDate>
            <guid isPermaLink="false">1997081</guid>        </item>
        <item>
            <title>Role of the ABC transporters ABCA1 and ABCG1 in foam cell formation and atherosclerosis</title>
            <link>http://www.medworm.com/index.php?rid=1997083&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.6.675%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , December 2008, Vol. 3, No. 6, Pages 675-687. 
		
	Enhancing reverse cholesterol transport from macrophages in the arterial wall to the liver for biliary excretion has been identified as a potential therapeutic strategy to reduce and eventually regress atherogenesis. In addition to HDL-raising therapies, ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1997083</comments>
            <pubDate>Fri, 28 Nov 2008 13:50:10 +0100</pubDate>
            <guid isPermaLink="false">1997083</guid>        </item>
        <item>
            <title>Intestinal postprandial chylomicrons: state of the union between liver, gut and dyslipidemia?</title>
            <link>http://www.medworm.com/index.php?rid=1829723&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.5.473%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , October 2008, Vol. 3, No. 5, Pages 473-480. (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1829723</comments>
            <pubDate>Fri, 26 Sep 2008 03:06:16 +0100</pubDate>
            <guid isPermaLink="false">1829723</guid>        </item>
        <item>
            <title>Dissecting NPC1L1-mediated cholesterol absorption</title>
            <link>http://www.medworm.com/index.php?rid=1829724&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.5.481%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , October 2008, Vol. 3, No. 5, Pages 481-484. (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1829724</comments>
            <pubDate>Thu, 25 Sep 2008 10:54:54 +0100</pubDate>
            <guid isPermaLink="false">1829724</guid>        </item>
        <item>
            <title>Long-term effects of trans fatty acid intake during pregnancy and lactation: does it have deleterious consequences?</title>
            <link>http://www.medworm.com/index.php?rid=1829726&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.5.489%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , October 2008, Vol. 3, No. 5, Pages 489-494. 
		
	 Evaluation of: Pisani LP, Oller do Nascimento CM, Bueno AA et al.: Hydrogenated fat diet intake during pregnancy and lactation modifies the PAI-1 gene expression in white adipose tissue of offspring in adult life. Lipids Health Dis. 7, 13 (2008). ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1829726</comments>
            <pubDate>Thu, 25 Sep 2008 10:54:53 +0100</pubDate>
            <guid isPermaLink="false">1829726</guid>        </item>
        <item>
            <title>Effect of exercise on lipolysis in adipose tissue</title>
            <link>http://www.medworm.com/index.php?rid=1829731&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.5.557%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , October 2008, Vol. 3, No. 5, Pages 557-572. 
		
	 Adipose tissue is a major source of nonesterified fatty acids, which are involved in the etiopathogenesis of several metabolic diseases. Mechanisms regulating the processes of lipolysis are of major importance because they represent potential drug ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1829731</comments>
            <pubDate>Thu, 25 Sep 2008 10:54:52 +0100</pubDate>
            <guid isPermaLink="false">1829731</guid>        </item>
        <item>
            <title>Apolipoprotein E and cholesterol in aging and disease in the brain</title>
            <link>http://www.medworm.com/index.php?rid=1829728&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.5.505%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , October 2008, Vol. 3, No. 5, Pages 505-530. 
		
	 Cholesterol can be detrimental or vital, and must be present in the right place at the right time and in the right amount. This is well known in the heart and the vascular system. However, in the CNS cholesterol is still an enigma, although several of ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1829728</comments>
            <pubDate>Thu, 25 Sep 2008 10:54:51 +0100</pubDate>
            <guid isPermaLink="false">1829728</guid>        </item>
        <item>
            <title>Apolipoprotein M: structure and function</title>
            <link>http://www.medworm.com/index.php?rid=1829727&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.5.495%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , October 2008, Vol. 3, No. 5, Pages 495-503. 
		
	 Lipoproteins in blood play an important physiological role transporting cholesterol, lipids and lipid-soluble substances to the different organs of the body. Diseases such as atherosclerosis, cardiovascular disease and stroke are associated with defects ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1829727</comments>
            <pubDate>Thu, 25 Sep 2008 10:54:48 +0100</pubDate>
            <guid isPermaLink="false">1829727</guid>        </item>
        <item>
            <title>DHCR7 mutations causing the Smith–Lemli–Opitz syndrome</title>
            <link>http://www.medworm.com/index.php?rid=1829733&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.5.585%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , October 2008, Vol. 3, No. 5, Pages 585-593. 
		
	 The Smith–Lemli–Opitz Syndrome (SLOS) is a metabolic malformation and mental retardation syndrome that is casued by a defect in cholesterol biosynthesis. The resulting loss of cholesterol leads to a spectrum from mild to very severe phenotype. The DHCR7 ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1829733</comments>
            <pubDate>Thu, 25 Sep 2008 10:54:45 +0100</pubDate>
            <guid isPermaLink="false">1829733</guid>        </item>
        <item>
            <title>Macrophage infiltration into adipose tissue: initiation, propagation and remodeling</title>
            <link>http://www.medworm.com/index.php?rid=1829730&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.5.545%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , October 2008, Vol. 3, No. 5, Pages 545-556. 
		
	 It has long been known that adipose tissue in obesity is in a heightened state of inflammation. Recently, our understanding of this has been transformed by the knowledge that immune cells such as macrophages and T cells can infiltrate adipose tissue and ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1829730</comments>
            <pubDate>Thu, 25 Sep 2008 10:54:44 +0100</pubDate>
            <guid isPermaLink="false">1829730</guid>        </item>
        <item>
            <title>Bulletin Board</title>
            <link>http://www.medworm.com/index.php?rid=1829725&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.5.485%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , October 2008, Vol. 3, No. 5, Pages 485-487. (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1829725</comments>
            <pubDate>Thu, 25 Sep 2008 10:54:43 +0100</pubDate>
            <guid isPermaLink="false">1829725</guid>        </item>
        <item>
            <title>Acknowledgements</title>
            <link>http://www.medworm.com/index.php?rid=1829734&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.5.597%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , October 2008, Vol. 3, No. 5, Pages 597-597. (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1829734</comments>
            <pubDate>Thu, 25 Sep 2008 10:54:40 +0100</pubDate>
            <guid isPermaLink="false">1829734</guid>        </item>
        <item>
            <title>Postprandial triglyceride-rich lipoproteins in insulin resistance and Type 2 diabetes</title>
            <link>http://www.medworm.com/index.php?rid=1829729&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.5.531%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , October 2008, Vol. 3, No. 5, Pages 531-543. 
		
	 Recent evidence from prospective epidemiological large-scale studies have provided convincing proof for the role of nonfasting triglycerides, carried in VLDL and chylomicrons, as an independent risk factor for cardiovascular disease and death. ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1829729</comments>
            <pubDate>Thu, 25 Sep 2008 10:54:40 +0100</pubDate>
            <guid isPermaLink="false">1829729</guid>        </item>
        <item>
            <title>Nutritional management of lipids for overweight and obesity: what can we achieve?</title>
            <link>http://www.medworm.com/index.php?rid=1829732&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.5.573%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , October 2008, Vol. 3, No. 5, Pages 573-584. 
		
	 Overweight and obesity are independent risk factors for cardiovascular disease. Many cardiovascular disease risk factors are elevated in overweight and obese individuals, including dyslipidemia and inflammation, among others. Current dietary ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1829732</comments>
            <pubDate>Thu, 25 Sep 2008 10:54:38 +0100</pubDate>
            <guid isPermaLink="false">1829732</guid>        </item>
        <item>
            <title>Clinical trials and surrogate end points: lessons from the ENHANCE trial</title>
            <link>http://www.medworm.com/index.php?rid=1631879&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.4.353%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , August 2008, Vol. 3, No. 4, Pages 353-357. (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1631879</comments>
            <pubDate>Thu, 17 Jul 2008 03:00:10 +0100</pubDate>
            <guid isPermaLink="false">1631879</guid>        </item>
        <item>
            <title>In vivo versus cell culture models: the example of lipid biosynthesis in the enterocyte</title>
            <link>http://www.medworm.com/index.php?rid=1631882&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.4.367%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>This report reviews the ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1631882</comments>
            <pubDate>Wed, 16 Jul 2008 10:59:19 +0100</pubDate>
            <guid isPermaLink="false">1631882</guid>        </item>
        <item>
            <title>Structure and function of the enigmatic Sec14 domain-containing proteins and the etiology of human disease</title>
            <link>http://www.medworm.com/index.php?rid=1631885&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.4.399%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , August 2008, Vol. 3, No. 4, Pages 399-410. 
		
	 Proteins containing the Sec14 domain, also referred to as the CRAL-TRIO domain, are found throughout Eukarya. Sec14 domains bind a single lipophilic molecule with the hydrophobic tail oriented toward the middle of the protein and the hydrophilic head ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1631885</comments>
            <pubDate>Wed, 16 Jul 2008 10:59:18 +0100</pubDate>
            <guid isPermaLink="false">1631885</guid>        </item>
        <item>
            <title>Sex-dependent differences in lipid handling and the implications for obesity-linked disorders</title>
            <link>http://www.medworm.com/index.php?rid=1631880&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.4.359%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , August 2008, Vol. 3, No. 4, Pages 359-361. (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1631880</comments>
            <pubDate>Wed, 16 Jul 2008 10:59:18 +0100</pubDate>
            <guid isPermaLink="false">1631880</guid>        </item>
        <item>
            <title>Risk of metabolic and vascular disease in South Asians: potential mechanisms for increased insulin resistance</title>
            <link>http://www.medworm.com/index.php?rid=1631886&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.4.411%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , August 2008, Vol. 3, No. 4, Pages 411-424. 
		
	 The impending global pandemic of obesity, Type 2 diabetes and vascular disease suggests an urgent need for prevention strategies. Of all the common ethnic groups, South Asians, who make up a fifth of the world’s population, experience the highest ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1631886</comments>
            <pubDate>Wed, 16 Jul 2008 10:59:17 +0100</pubDate>
            <guid isPermaLink="false">1631886</guid>        </item>
        <item>
            <title>Roles of eicosanoids in prostate cancer</title>
            <link>http://www.medworm.com/index.php?rid=1631889&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.4.453%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , August 2008, Vol. 3, No. 4, Pages 453-467. 
		
	 Arachidonic acid (AA) is metabolized by oxygenases to numerous biologically active eicosanoids. For example, AA is metabolized by COX to prostaglandins (PGs) and thromboxanes, by lipoxygenases (LOX) to leukotrienes and hydroxyeicosatetraenoic acids (... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1631889</comments>
            <pubDate>Wed, 16 Jul 2008 10:59:15 +0100</pubDate>
            <guid isPermaLink="false">1631889</guid>        </item>
        <item>
            <title>Apolipoprotein AV: gene expression, physiological role in lipid metabolism and clinical relevance</title>
            <link>http://www.medworm.com/index.php?rid=1631883&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.4.371%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , August 2008, Vol. 3, No. 4, Pages 371-384. 
		
	 The apolipoprotein APOA5 gene, a member of the gene cluster on chromosome 11q23 that includes APOA1, APOC3 and APOA4, has gained considerable interest as it encodes ApoAV, a key determinant of circulating levels of potentially atherogenic triglyceride-... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1631883</comments>
            <pubDate>Wed, 16 Jul 2008 10:59:14 +0100</pubDate>
            <guid isPermaLink="false">1631883</guid>        </item>
        <item>
            <title>Role of lipoprotein lipase in triglyceride metabolism: potential therapeutic target</title>
            <link>http://www.medworm.com/index.php?rid=1631884&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.4.385%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , August 2008, Vol. 3, No. 4, Pages 385-397. 
		
	 Moderately elevated plasma triglyceride levels contribute to increased risk for cardiovascular disease, whereas severe hypertriglyceridemia (fasting plasma triglyceride &gt;10 mmol/l) is associated with an increased risk of pancreatitis. The enzyme ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1631884</comments>
            <pubDate>Wed, 16 Jul 2008 10:59:11 +0100</pubDate>
            <guid isPermaLink="false">1631884</guid>        </item>
        <item>
            <title>Researchers identify the role of the XBP1 transcription factor in cholesterol production in the liver</title>
            <link>http://www.medworm.com/index.php?rid=1631881&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.4.363%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , August 2008, Vol. 3, No. 4, Pages 363-365. (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1631881</comments>
            <pubDate>Wed, 16 Jul 2008 10:59:10 +0100</pubDate>
            <guid isPermaLink="false">1631881</guid>        </item>
        <item>
            <title>Ganglioside complexes as target antigens in Guillain–Barré syndrome and related disorders</title>
            <link>http://www.medworm.com/index.php?rid=1631887&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.4.425%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , August 2008, Vol. 3, No. 4, Pages 425-434. 
		
	 Recent data demonstrate that sera from patients with Guillain–Barré syndrome react with ganglioside complexes (GSCs) consisting of two different gangliosides, but not with each constituent ganglioside. GSCs are likely to express conformationally ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1631887</comments>
            <pubDate>Wed, 16 Jul 2008 10:59:09 +0100</pubDate>
            <guid isPermaLink="false">1631887</guid>        </item>
        <item>
            <title>The ins and outs of endocannabinoid signaling in healthy and diseased brain</title>
            <link>http://www.medworm.com/index.php?rid=1631888&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.4.435%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , August 2008, Vol. 3, No. 4, Pages 435-452. 
		
	 The endocannabinoid signaling system regulates neuronal activity and glial cell function. While numerous studies exist on the pharmacology and coupling of cannabinoid receptors, only recently have fundamental questions been addressed regarding ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1631888</comments>
            <pubDate>Wed, 16 Jul 2008 10:59:08 +0100</pubDate>
            <guid isPermaLink="false">1631888</guid>        </item>
        <item>
            <title>Acknowledgements</title>
            <link>http://www.medworm.com/index.php?rid=1631890&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.4.471%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , August 2008, Vol. 3, No. 4, Pages 471-471. (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1631890</comments>
            <pubDate>Wed, 16 Jul 2008 10:59:07 +0100</pubDate>
            <guid isPermaLink="false">1631890</guid>        </item>
        <item>
            <title>Myriocin as an atherosclerosis inhibitor</title>
            <link>http://www.medworm.com/index.php?rid=1455172&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.3.221%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , June 2008, Vol. 3, No. 3, Pages 221-224. (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1455172</comments>
            <pubDate>Tue, 20 May 2008 03:01:08 +0100</pubDate>
            <guid isPermaLink="false">1455172</guid>        </item>
        <item>
            <title>Evaluation of phospholipid transfer protein as a therapeutic target</title>
            <link>http://www.medworm.com/index.php?rid=1455183&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.3.327%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , June 2008, Vol. 3, No. 3, Pages 327-335. 
		
	 Phospholipid transfer protein (PLTP) plays an essential role in lipoprotein metabolism. Deficiency or overexpression of PLTP in animal models results in modulation of the atherosclerotic process. Moreover, PLTP has also been implicated in obesity and ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1455183</comments>
            <pubDate>Mon, 19 May 2008 10:45:49 +0100</pubDate>
            <guid isPermaLink="false">1455183</guid>        </item>
        <item>
            <title>Colesevelam hydrochloride: a specifically engineered bile acid sequestrant</title>
            <link>http://www.medworm.com/index.php?rid=1455176&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.3.237%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , June 2008, Vol. 3, No. 3, Pages 237-255. 
		
	 There is a well established association between serum cholesterol and coronary heart disease and this relationship has been found to be related to concentration and is continuous over the entire distribution of cholesterol levels. Recent studies have ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1455176</comments>
            <pubDate>Mon, 19 May 2008 10:45:48 +0100</pubDate>
            <guid isPermaLink="false">1455176</guid>        </item>
        <item>
            <title>Status of cardiolipin synthesis in heart failure</title>
            <link>http://www.medworm.com/index.php?rid=1455181&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.3.311%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , June 2008, Vol. 3, No. 3, Pages 311-317. 
		
	 Phospholipids are important structural and functional components of all biological membranes. The mitochondrial phospholipid, cardiolipin, comprises approximately 15% of the entire phospholipid mass of the heart. Cardiolipin plays an important role in ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1455181</comments>
            <pubDate>Mon, 19 May 2008 10:45:46 +0100</pubDate>
            <guid isPermaLink="false">1455181</guid>        </item>
        <item>
            <title>Fatty liver and HDL-cholesterol: just a matter of quantity?</title>
            <link>http://www.medworm.com/index.php?rid=1455173&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.3.225%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , June 2008, Vol. 3, No. 3, Pages 225-227. (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1455173</comments>
            <pubDate>Mon, 19 May 2008 10:45:46 +0100</pubDate>
            <guid isPermaLink="false">1455173</guid>        </item>
        <item>
            <title>Statins in stroke prevention</title>
            <link>http://www.medworm.com/index.php?rid=1455182&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.3.319%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , June 2008, Vol. 3, No. 3, Pages 319-325. 
		
	 Beside blood pressure-lowering drugs and, in certain circumstances, antithrombotic agents, statins are among the most effective drugs in reducing the risk of stroke in populations of patients at high vascular risk, as well as reducing the risk of major ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1455182</comments>
            <pubDate>Mon, 19 May 2008 10:45:45 +0100</pubDate>
            <guid isPermaLink="false">1455182</guid>        </item>
        <item>
            <title>The case against ApoB and the ApoB:ApoA-I ratio: are they right?</title>
            <link>http://www.medworm.com/index.php?rid=1455177&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.3.257%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , June 2008, Vol. 3, No. 3, Pages 257-264. 
		
	 Based on similar predictive powers, the investigators of the Framingham Offspring Study concluded that the total cholesterol:HDL-cholesterol and the ApoB:ApoA-I ratios were equivalent markers of cardiovascular risk. Since the apolipoprotein ratio offered ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1455177</comments>
            <pubDate>Mon, 19 May 2008 10:45:45 +0100</pubDate>
            <guid isPermaLink="false">1455177</guid>        </item>
        <item>
            <title>Phytosterols in cardiovascular disease: innocuous dietary components, or accelerators of atherosclerosis?</title>
            <link>http://www.medworm.com/index.php?rid=1455180&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.3.301%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , June 2008, Vol. 3, No. 3, Pages 301-310. 
		
	 Plant sterols (phytosterols) are a normal component of the diet. Their uptake and elimination is tightly controlled, so that only very low levels are normally found in plasma. However, rare mutations in genes responsible for phytosterol elimination lead ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1455180</comments>
            <pubDate>Mon, 19 May 2008 10:45:44 +0100</pubDate>
            <guid isPermaLink="false">1455180</guid>        </item>
        <item>
            <title>Ceramide signaling in cancer and stem cells</title>
            <link>http://www.medworm.com/index.php?rid=1455179&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.3.273%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , June 2008, Vol. 3, No. 3, Pages 273-300. 
		
	 Most of the previous work on the sphingolipid ceramide has been devoted to its function as an apoptosis inducer. Recent studies, however, have shown that in stem cells, ceramide has additional nonapoptotic functions. In this article, ceramide signaling ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1455179</comments>
            <pubDate>Mon, 19 May 2008 10:45:43 +0100</pubDate>
            <guid isPermaLink="false">1455179</guid>        </item>
        <item>
            <title>Regulation of cellular steroid levels with special focus on oxysterol and estrogen metabolism</title>
            <link>http://www.medworm.com/index.php?rid=1455184&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.3.337%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , June 2008, Vol. 3, No. 3, Pages 337-346. 
		
	 Steroids play essential roles in a number of physiological systems. However, disturbed functions or abnormal levels of steroids can result in serious health problems. The cellular levels of steroids are regulated by enzymes and other factors that control ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1455184</comments>
            <pubDate>Mon, 19 May 2008 10:45:39 +0100</pubDate>
            <guid isPermaLink="false">1455184</guid>        </item>
        <item>
            <title>Results of the ENHANCE study presented</title>
            <link>http://www.medworm.com/index.php?rid=1455175&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.3.233%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , June 2008, Vol. 3, No. 3, Pages 233-235. (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1455175</comments>
            <pubDate>Mon, 19 May 2008 10:45:39 +0100</pubDate>
            <guid isPermaLink="false">1455175</guid>        </item>
        <item>
            <title>Acknowledgements</title>
            <link>http://www.medworm.com/index.php?rid=1455185&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.3.351%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , June 2008, Vol. 3, No. 3, Pages 351-351. (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1455185</comments>
            <pubDate>Mon, 19 May 2008 10:45:38 +0100</pubDate>
            <guid isPermaLink="false">1455185</guid>        </item>
        <item>
            <title>Compartmentalizing oxidative stress</title>
            <link>http://www.medworm.com/index.php?rid=1455174&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.3.229%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , June 2008, Vol. 3, No. 3, Pages 229-231. (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1455174</comments>
            <pubDate>Mon, 19 May 2008 10:45:38 +0100</pubDate>
            <guid isPermaLink="false">1455174</guid>        </item>
        <item>
            <title>Potential roles for inhibitors of arachidonic acid metabolism in prevention and treatment of breast cancer</title>
            <link>http://www.medworm.com/index.php?rid=1455178&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.3.265%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , June 2008, Vol. 3, No. 3, Pages 265-271. 
		
	 Breast cancer is the second leading cause of female cancer-related deaths between the ages of 40 and 50 years in industrialized nations. The essential fatty acid arachidonic acid is suggested to play an important role in the development of various ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1455178</comments>
            <pubDate>Mon, 19 May 2008 10:45:37 +0100</pubDate>
            <guid isPermaLink="false">1455178</guid>        </item>
        <item>
            <title>Lipase maturation factor 1 (Lmf1), a new gene in hypertriglyceridemia</title>
            <link>http://www.medworm.com/index.php?rid=1312559&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.2.119%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , April 2008, Vol. 3, No. 2, Pages 119-122. (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1312559</comments>
            <pubDate>Wed, 19 Mar 2008 03:00:18 +0100</pubDate>
            <guid isPermaLink="false">1312559</guid>        </item>
        <item>
            <title>GPIHBP1: a new chylomicronemia gene</title>
            <link>http://www.medworm.com/index.php?rid=1312569&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.2.203%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , April 2008, Vol. 3, No. 2, Pages 203-216. 
		
	 Gpihbp1-deficient mice exhibit severe chylomicronemia, even on a low-fat diet, with grossly lipemic plasma and plasma triglyceride levels as high as 5000 mg/dl. GPIHBP1 is expressed on the luminal surface of endothelial cells of heart, muscle and fat, ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1312569</comments>
            <pubDate>Tue, 18 Mar 2008 15:38:09 +0100</pubDate>
            <guid isPermaLink="false">1312569</guid>        </item>
        <item>
            <title>Dyslipidemia and Type 2 diabetes in children below 18 years of age: an approaching avalanche</title>
            <link>http://www.medworm.com/index.php?rid=1312560&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.2.123%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , April 2008, Vol. 3, No. 2, Pages 123-125. (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1312560</comments>
            <pubDate>Tue, 18 Mar 2008 15:38:05 +0100</pubDate>
            <guid isPermaLink="false">1312560</guid>        </item>
        <item>
            <title>Genetic basis of the lipid storage disorders</title>
            <link>http://www.medworm.com/index.php?rid=1312568&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.2.189%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , April 2008, Vol. 3, No. 2, Pages 189-201. 
		
	 The lipid storage diseases are a family of inherited disorders that result from the deficiency of a specific enzyme activity and the accumulation of complex lipid substrates in the lysosome, resulting in physiologic and morphologic alterations that lead ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1312568</comments>
            <pubDate>Tue, 18 Mar 2008 15:38:04 +0100</pubDate>
            <guid isPermaLink="false">1312568</guid>        </item>
        <item>
            <title>HDL-C particle size and levels may be determinants for risk of a major coronary event</title>
            <link>http://www.medworm.com/index.php?rid=1312562&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.2.129%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , April 2008, Vol. 3, No. 2, Pages 129-131. (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1312562</comments>
            <pubDate>Tue, 18 Mar 2008 15:38:04 +0100</pubDate>
            <guid isPermaLink="false">1312562</guid>        </item>
        <item>
            <title>Role of stearoyl-CoA desaturase in human metabolic disease</title>
            <link>http://www.medworm.com/index.php?rid=1312566&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.2.163%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , April 2008, Vol. 3, No. 2, Pages 163-173. 
		
	 Stearoyl-CoA desaturase (SCD) is a highly conserved Δ-9 desaturase that converts saturated fatty acids into monounsaturated fatty acids. Mice lacking the Scd1 gene are characterized by decreased adiposity and increased lipid oxidation and insulin ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1312566</comments>
            <pubDate>Tue, 18 Mar 2008 15:38:03 +0100</pubDate>
            <guid isPermaLink="false">1312566</guid>        </item>
        <item>
            <title>Focus on the unprotective role of elevated HDL-C in unstable angina</title>
            <link>http://www.medworm.com/index.php?rid=1312561&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.2.127%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , April 2008, Vol. 3, No. 2, Pages 127-128. (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1312561</comments>
            <pubDate>Tue, 18 Mar 2008 15:38:01 +0100</pubDate>
            <guid isPermaLink="false">1312561</guid>        </item>
        <item>
            <title>Can we prevent Parkinson’s disease with n-3 polyunsaturated fatty acids?</title>
            <link>http://www.medworm.com/index.php?rid=1312563&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.2.133%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , April 2008, Vol. 3, No. 2, Pages 133-137. 
		
	 It is increasingly clear that nongenetic elements play a crucial role in the pathogenesis of Parkinson’s disease (PD), yet no modifiable environmental risk factor has been clearly identified. Recent work in animal models of PD supports the contention ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1312563</comments>
            <pubDate>Tue, 18 Mar 2008 15:38:00 +0100</pubDate>
            <guid isPermaLink="false">1312563</guid>        </item>
        <item>
            <title>Therapeutic potential of antiangiogenic agents for prevention and treatment of obesity</title>
            <link>http://www.medworm.com/index.php?rid=1312565&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.2.153%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , April 2008, Vol. 3, No. 2, Pages 153-162. 
		
	 Accumulating evidence demonstrates that growing adipose tissues produce various pro-angiogenic factors, cytokines and adipokines, which induce neovascularization. Similar to malignant tissue growth, expansion of fat mass would not be achieved without ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1312565</comments>
            <pubDate>Tue, 18 Mar 2008 15:37:59 +0100</pubDate>
            <guid isPermaLink="false">1312565</guid>        </item>
        <item>
            <title>Prevalence of obesity amongst Chinese populations revisited</title>
            <link>http://www.medworm.com/index.php?rid=1312564&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.2.139%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , April 2008, Vol. 3, No. 2, Pages 139-152. 
		
	 As in Western populations, the prevalence of obesity has been increasing rapidly in Chinese populations in recent years, but if the same criteria to define obesity are used, it is still much less common in Chinese than in Caucasians. For BMI greater or ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1312564</comments>
            <pubDate>Tue, 18 Mar 2008 15:37:56 +0100</pubDate>
            <guid isPermaLink="false">1312564</guid>        </item>
        <item>
            <title>Current and future treatments of HIV-associated dyslipidemia</title>
            <link>http://www.medworm.com/index.php?rid=1312567&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.2.175%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , April 2008, Vol. 3, No. 2, Pages 175-188. 
		
	 The dyslipidemia associated with HIV is common and is attributed to HIV itself and/or the antiretroviral therapy used to treat HIV. The treatment of this dyslipidemia includes lifestyle changes, such as diet and exercise, altering the antiretroviral ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1312567</comments>
            <pubDate>Tue, 18 Mar 2008 15:37:54 +0100</pubDate>
            <guid isPermaLink="false">1312567</guid>        </item>
        <item>
            <title>Is there a place for LDL-apheresis in the management of raised cholesterol?</title>
            <link>http://www.medworm.com/index.php?rid=1184808&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.1.1%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , February 2008, Vol. 3, No. 1, Pages 1-3. (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1184808</comments>
            <pubDate>Tue, 29 Jan 2008 04:01:06 +0100</pubDate>
            <guid isPermaLink="false">1184808</guid>        </item>
        <item>
            <title>Obesity and contraception</title>
            <link>http://www.medworm.com/index.php?rid=1184816&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.1.75%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , February 2008, Vol. 3, No. 1, Pages 75-81. 
		
	 Obesity is an important public health issue in England and Wales and is a predictor of mortality in women. In the USA and UK the epidemic of obesity is worsening. In the USA, 33% of the population is obese and obesity causes 400,000 deaths every year. In ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1184816</comments>
            <pubDate>Mon, 28 Jan 2008 14:18:02 +0100</pubDate>
            <guid isPermaLink="false">1184816</guid>        </item>
        <item>
            <title>Detection of small dense LDL-cholesterol: is it necessary to determine particle size?</title>
            <link>http://www.medworm.com/index.php?rid=1184812&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.1.23%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , February 2008, Vol. 3, No. 1, Pages 23-25. 
		
	 Evaluation of: Julius U, Dittrich M, Pietzsch J: Factors influencing the formation of small dense low-density lipoprotein particles in dependence on the presence of the metabolic syndrome and on the degree of glucose intolerance. Int. J. Clin. Pract. 61(... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1184812</comments>
            <pubDate>Mon, 28 Jan 2008 14:18:02 +0100</pubDate>
            <guid isPermaLink="false">1184812</guid>        </item>
        <item>
            <title>Apolipoprotein E and anxiety</title>
            <link>http://www.medworm.com/index.php?rid=1184818&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.1.97%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , February 2008, Vol. 3, No. 1, Pages 97-103. 
		
	 Apolipoprotein E4 is a risk factor for developing Alzheimer’s disease (AD) at an earlier age. Anxiety is most common in AD patients with an age-at-onset under 65 years old. We hypothesize that differential effects of human ApoE isoforms on anxiety ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1184818</comments>
            <pubDate>Mon, 28 Jan 2008 14:18:01 +0100</pubDate>
            <guid isPermaLink="false">1184818</guid>        </item>
        <item>
            <title>Role of PPAR-γ2 polymorphisms in bodyweight regulation</title>
            <link>http://www.medworm.com/index.php?rid=1184814&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.1.31%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , February 2008, Vol. 3, No. 1, Pages 31-41. 
		
	 Peroxisome proliferator-activated receptor (PPAR)-γ2 is an adipose tissue-specific nuclear hormone receptor that regulates adipocytes differentiation and fat metabolism through a complex program concerning gene expression. This transcription factor, ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1184814</comments>
            <pubDate>Mon, 28 Jan 2008 14:18:01 +0100</pubDate>
            <guid isPermaLink="false">1184814</guid>        </item>
        <item>
            <title>Metabolic syndrome may increase operative mortality in patients undergoing coronary artery bypass graft surgery</title>
            <link>http://www.medworm.com/index.php?rid=1184813&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.1.27%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , February 2008, Vol. 3, No. 1, Pages 27-29. 
		
	 Evaluation of: Echahidi N, Pibarot P, Despres JP et al.: Metabolic syndrome increases operative mortality in patients undergoing coronary artery bypass grafting surgery. J. Am. Coll. Cardiol. 50(8), 843–851 (2007). Metabolic syndrome (MS) is associated ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1184813</comments>
            <pubDate>Mon, 28 Jan 2008 14:18:01 +0100</pubDate>
            <guid isPermaLink="false">1184813</guid>        </item>
        <item>
            <title>Macronutrients and obesity: views, news and reviews</title>
            <link>http://www.medworm.com/index.php?rid=1184815&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.1.43%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , February 2008, Vol. 3, No. 1, Pages 43-74. 
		
	 Profound changes in macronutrient composition of food have taken place since the agricultural revolution, leading to a higher dietary intake of carbohydrates at the expense of protein, and a dramatically increased intake of n-6 polyunsaturated fatty ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1184815</comments>
            <pubDate>Mon, 28 Jan 2008 14:18:00 +0100</pubDate>
            <guid isPermaLink="false">1184815</guid>        </item>
        <item>
            <title>Study identifies genes linked to cholesterol levels</title>
            <link>http://www.medworm.com/index.php?rid=1184809&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.1.5%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , February 2008, Vol. 3, No. 1, Pages 5-7. (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1184809</comments>
            <pubDate>Mon, 28 Jan 2008 14:18:00 +0100</pubDate>
            <guid isPermaLink="false">1184809</guid>        </item>
        <item>
            <title>Systems-biology approach to sphingolipid-storage disorders</title>
            <link>http://www.medworm.com/index.php?rid=1184819&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.1.105%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , February 2008, Vol. 3, No. 1, Pages 105-111. 
		
	 The discovery of the enzymatic defects in sphingolipid-storage disorders led to important benefits for patients with these conditions. Diagnostic tests, genetic counseling procedures and prenatal diagnosis are available for these disorders. Enzyme-... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1184819</comments>
            <pubDate>Mon, 28 Jan 2008 14:17:59 +0100</pubDate>
            <guid isPermaLink="false">1184819</guid>        </item>
        <item>
            <title>Cholesterol metabolism and noncholesterol sterol distribution in lipoproteins of Type 1 diabetes</title>
            <link>http://www.medworm.com/index.php?rid=1184811&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.1.17%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , February 2008, Vol. 3, No. 1, Pages 17-21. 
		
	 Evaluation of: Sittiwet C, Gylling H, Hallikainen M: The effect of improved glycaemic control on cholesterol metabolism and non-cholesterol sterol distribution in Type 1 diabetic patients. Atherosclerosis 194, 465–472 (2007). The dyslipidemia of ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1184811</comments>
            <pubDate>Mon, 28 Jan 2008 14:17:59 +0100</pubDate>
            <guid isPermaLink="false">1184811</guid>        </item>
        <item>
            <title>Link between small-vessel vasculitides and atherosclerosis</title>
            <link>http://www.medworm.com/index.php?rid=1184817&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.1.83%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , February 2008, Vol. 3, No. 1, Pages 83-95. 
		
	 Premature atherosclerosis has recently emerged as a late, but possibly severe, complication of systemic small-vessel vasculitides, mainly represented by Wegener’s granulomatosis, microscopic polyangiitis and Churg–Strauss syndrome. We review herein the ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1184817</comments>
            <pubDate>Mon, 28 Jan 2008 14:17:58 +0100</pubDate>
            <guid isPermaLink="false">1184817</guid>        </item>
        <item>
            <title>Use of extended-release niacin in clinical practice</title>
            <link>http://www.medworm.com/index.php?rid=1184810&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.3.1.9%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , February 2008, Vol. 3, No. 1, Pages 9-16. 
		
	 Alteration of the lipid profile is the foundation of both primary and secondary prevention of coronary artery disease. Statins have become the gold standard for lowering LDL-cholesterol levels; however, an increasing number of studies have shown the ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1184810</comments>
            <pubDate>Mon, 28 Jan 2008 14:17:58 +0100</pubDate>
            <guid isPermaLink="false">1184810</guid>        </item>
        <item>
            <title>Unlocking the molecular basis of obesity</title>
            <link>http://www.medworm.com/index.php?rid=1055875&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.2.6.577%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , Dec 2007, Vol. 2, No. 6, Pages 577-581. (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1055875</comments>
            <pubDate>Wed, 28 Nov 2007 04:04:19 +0100</pubDate>
            <guid isPermaLink="false">1055875</guid>        </item>
        <item>
            <title>Role of adaptive thermogenesis in unsuccessful weight-loss intervention</title>
            <link>http://www.medworm.com/index.php?rid=1055885&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.2.6.651%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , Dec 2007, Vol. 2, No. 6, Pages 651-658. 
		
	 Numerous studies have been performed to examine the existence of a relationship between a weak thermogenic potential and the risk of developing obesity. These studies used a large variety of methodological approaches that have frequently revealed a ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1055885</comments>
            <pubDate>Tue, 27 Nov 2007 11:42:48 +0100</pubDate>
            <guid isPermaLink="false">1055885</guid>        </item>
        <item>
            <title>Thyroid hormone receptor subtype-β-selective agonists as potential treatments for metabolic syndrome</title>
            <link>http://www.medworm.com/index.php?rid=1055884&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.2.6.641%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , Dec 2007, Vol. 2, No. 6, Pages 641-649. 
		
	 Thyroid hormones are of interest because of their ability to reduce serum cholesterol and triglycerides and their ability to reduce adiposity. Unfortunately, naturally occurring thyroid hormones, such as T3 (thyroid hormone) or T4 (thyroxine), cannot be ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1055884</comments>
            <pubDate>Tue, 27 Nov 2007 11:42:44 +0100</pubDate>
            <guid isPermaLink="false">1055884</guid>        </item>
        <item>
            <title>Targeting liver X receptor β: a new therapeutic approach to prevent atherosclerosis?</title>
            <link>http://www.medworm.com/index.php?rid=1055880&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.2.6.603%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , Dec 2007, Vol. 2, No. 6, Pages 603-607. 
		
	 Evaluation of: Bradley MN, Hong C, Chen M et al.: Ligand activation of LXR β reverses atherosclerosis and cellular cholesterol overload in mice lacking LXR α and ApoE. J. Clin. Invest. 117, 2337–2346 (2007). The increase in cardiovascular disease and its ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1055880</comments>
            <pubDate>Tue, 27 Nov 2007 11:42:42 +0100</pubDate>
            <guid isPermaLink="false">1055880</guid>        </item>
        <item>
            <title>Unraveling the functions of macrophage transporters by measuring macrophage-specific reverse cholesterol transport in vivo</title>
            <link>http://www.medworm.com/index.php?rid=1055881&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.2.6.609%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , Dec 2007, Vol. 2, No. 6, Pages 609-613. 
		
	 Evaluation of: Wang X, Collins HL, Ranalletta M et al.: Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. J. Clin. Invest. 117(8), 2216–2224 (2007). Although the role of ATP-binding cassette (ABC)A1, ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1055881</comments>
            <pubDate>Tue, 27 Nov 2007 11:42:41 +0100</pubDate>
            <guid isPermaLink="false">1055881</guid>        </item>
        <item>
            <title>Genetics of familial hypobetalipoproteinemia</title>
            <link>http://www.medworm.com/index.php?rid=1055882&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.2.6.615%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , Dec 2007, Vol. 2, No. 6, Pages 615-624. 
		
	 Primary hypobetalipoproteinemias include three monogenic disorders: the relatively frequent codominant familial hypobetalipoproteinemia (FHBL), the rare recessive conditions abetalipoproteinemia (ABL) and chylomicron retention disease (CMRD). ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1055882</comments>
            <pubDate>Tue, 27 Nov 2007 11:42:40 +0100</pubDate>
            <guid isPermaLink="false">1055882</guid>        </item>
        <item>
            <title>Contribution of sphingolipids to the pathogenesis of obesity</title>
            <link>http://www.medworm.com/index.php?rid=1055883&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.2.6.625%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , Dec 2007, Vol. 2, No. 6, Pages 625-639. 
		
	 Insulin resistance, Type 2 diabetes and accelerated atherosclerosis are common health complications associated with obesity, and increasing evidence suggest that a complex proinflammatory state together with increased lipid accumulation in extra adipose ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1055883</comments>
            <pubDate>Tue, 27 Nov 2007 11:42:38 +0100</pubDate>
            <guid isPermaLink="false">1055883</guid>        </item>
        <item>
            <title>Pathways involved in lipid-induced insulin resistance in obesity</title>
            <link>http://www.medworm.com/index.php?rid=1055886&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.2.6.659%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , Dec 2007, Vol. 2, No. 6, Pages 659-667. 
		
	 The rapid rise in the incidence of obesity has led to an epidemic of insulin resistance that is a key contributor to the development of cardiovascular disease and Type 2 diabetes. Since insulin resistance precedes the development of these diseases by up ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1055886</comments>
            <pubDate>Tue, 27 Nov 2007 11:42:37 +0100</pubDate>
            <guid isPermaLink="false">1055886</guid>        </item>
        <item>
            <title>Impact of statin therapy on the artery wall in the low-risk patient: implications from the METEOR study</title>
            <link>http://www.medworm.com/index.php?rid=1055879&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.2.6.595%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , Dec 2007, Vol. 2, No. 6, Pages 595-601. 
		
	 Lowering levels of LDL-cholesterol is associated with profound clinical benefit. More recently, it has been demonstrated that intensively lowering LDL-cholesterol to very low levels is associated with greater benefit. Vascular imaging has defined that ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1055879</comments>
            <pubDate>Tue, 27 Nov 2007 11:42:36 +0100</pubDate>
            <guid isPermaLink="false">1055879</guid>        </item>
        <item>
            <title>Study reports on worldwide obesity 'pandemic’</title>
            <link>http://www.medworm.com/index.php?rid=1055878&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.2.6.591%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , Dec 2007, Vol. 2, No. 6, Pages 591-593. (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1055878</comments>
            <pubDate>Tue, 27 Nov 2007 08:00:00 +0100</pubDate>
            <guid isPermaLink="false">1055878</guid>        </item>
        <item>
            <title>Modified lipoproteins as contrast agents for molecular imaging</title>
            <link>http://www.medworm.com/index.php?rid=1055877&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.2.6.587%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , Dec 2007, Vol. 2, No. 6, Pages 587-590. (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1055877</comments>
            <pubDate>Tue, 27 Nov 2007 08:00:00 +0100</pubDate>
            <guid isPermaLink="false">1055877</guid>        </item>
        <item>
            <title>Effect of diet on hormone-induced lipolysis</title>
            <link>http://www.medworm.com/index.php?rid=1055876&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.2.6.583%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , Dec 2007, Vol. 2, No. 6, Pages 583-585. (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1055876</comments>
            <pubDate>Tue, 27 Nov 2007 08:00:00 +0100</pubDate>
            <guid isPermaLink="false">1055876</guid>        </item>
        <item>
            <title>Are statins overused?</title>
            <link>http://www.medworm.com/index.php?rid=948112&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.2.5.481%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , Oct 2007, Vol. 2, No. 5, Pages 481-483. (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=948112</comments>
            <pubDate>Sat, 13 Oct 2007 03:00:17 +0100</pubDate>
            <guid isPermaLink="false">948112</guid>        </item>
        <item>
            <title>Surgical intervention for the treatment of morbid obesity and the dyslipidemias</title>
            <link>http://www.medworm.com/index.php?rid=948118&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.2.5.513%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , Oct 2007, Vol. 2, No. 5, Pages 513-525. 
		
	 To meet the expanding epidemic of worldwide morbid obesity, giving rise to significant dyslipidemia, knowledge of the surgical history of the development of the partial ileal bypass operation, the contribution of the Program on the Surgical Control of ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=948118</comments>
            <pubDate>Fri, 12 Oct 2007 09:57:56 +0100</pubDate>
            <guid isPermaLink="false">948118</guid>        </item>
        <item>
            <title>Could cholesterol hold the key to defeating sleeping sickness?</title>
            <link>http://www.medworm.com/index.php?rid=948116&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.2.5.499%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , Oct 2007, Vol. 2, No. 5, Pages 499-502. 
		
	 Etienne Pays is a Belgian molecular biologist and professor at the Université Libre de Bruxelles, specializing in trypanosome infection. The trypanosome parasite causes sleeping sickness in humans, a disease endemic in Africa that infects 300,000 people ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=948116</comments>
            <pubDate>Fri, 12 Oct 2007 09:57:54 +0100</pubDate>
            <guid isPermaLink="false">948116</guid>        </item>
        <item>
            <title>Sources of variability of plasma HDL-cholesterol levels</title>
            <link>http://www.medworm.com/index.php?rid=948122&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.2.5.557%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , Oct 2007, Vol. 2, No. 5, Pages 557-569. 
		
	 Epidemiological data from the Framingham and other prospective studies suggests an inverse correlation between the plasma concentration of HDL-cholesterol (HDL-C) and the incidence of cardiovascular disease. The relationship between HDL-C and its ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=948122</comments>
            <pubDate>Fri, 12 Oct 2007 09:57:50 +0100</pubDate>
            <guid isPermaLink="false">948122</guid>        </item>
        <item>
            <title>Potential therapeutic roles of lysophospholipid signaling in autoimmune-related disease</title>
            <link>http://www.medworm.com/index.php?rid=948120&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.2.5.535%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , Oct 2007, Vol. 2, No. 5, Pages 535-545. 
		
	 Autoimmune disorders are characterized by lymphocyte infiltration and destruction of affected tissues. Lysophospholipids are small, relatively simple phospholipids derived from cell membranes that have been shown over the last decade to produce a wide ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=948120</comments>
            <pubDate>Fri, 12 Oct 2007 09:57:49 +0100</pubDate>
            <guid isPermaLink="false">948120</guid>        </item>
        <item>
            <title>Mechanisms underlying fat-induced hepatic insulin resistance</title>
            <link>http://www.medworm.com/index.php?rid=948117&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.2.5.503%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , Oct 2007, Vol. 2, No. 5, Pages 503-512. 
		
	 Free fatty acids (FFAs), which are often elevated in obesity, cause insulin resistance. While the effects of FFAs on muscle glucose metabolism are well known, the mechanisms by which FFAs cause hepatic insulin resistance are incompletely understood. ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=948117</comments>
            <pubDate>Fri, 12 Oct 2007 09:57:46 +0100</pubDate>
            <guid isPermaLink="false">948117</guid>        </item>
        <item>
            <title>Role for glycocalyx perturbation in atherosclerosis development and associated microvascular dysfunction</title>
            <link>http://www.medworm.com/index.php?rid=948119&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.2.5.527%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , Oct 2007, Vol. 2, No. 5, Pages 527-534. 
		
	 The importance of the endothelial glycocalyx for vascular homeostasis is becoming more and more evident. This review addresses the potential relation between a damaged glycocalyx and the process of atherosclerosis, including the associated impairment in ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=948119</comments>
            <pubDate>Fri, 12 Oct 2007 09:57:43 +0100</pubDate>
            <guid isPermaLink="false">948119</guid>        </item>
        <item>
            <title>Inhibiting lipid absorption using basic biopolymers</title>
            <link>http://www.medworm.com/index.php?rid=948121&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.2.5.547%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , Oct 2007, Vol. 2, No. 5, Pages 547-555. 
		
	 Pancreatic lipase is a key enzyme in dietary triacylglycerol degradation, hydrolyzing triacylglycerols to 2-monoacylglycerol and fatty acids. Inhibitors of pancreatic lipase are able to suppress the absorption of dietary fat from the small intestine. ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=948121</comments>
            <pubDate>Fri, 12 Oct 2007 09:57:41 +0100</pubDate>
            <guid isPermaLink="false">948121</guid>        </item>
        <item>
            <title>Why does good cholesterol go bad?</title>
            <link>http://www.medworm.com/index.php?rid=948115&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.2.5.495%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , Oct 2007, Vol. 2, No. 5, Pages 495-497. (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=948115</comments>
            <pubDate>Fri, 12 Oct 2007 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">948115</guid>        </item>
        <item>
            <title>Inflammation, dyslipidemia and risks of ischemic strokes in systemic lupus erythematosus</title>
            <link>http://www.medworm.com/index.php?rid=948114&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.2.5.489%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , Oct 2007, Vol. 2, No. 5, Pages 489-493. (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=948114</comments>
            <pubDate>Fri, 12 Oct 2007 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">948114</guid>        </item>
        <item>
            <title>Are dietary preferences linked to genes?</title>
            <link>http://www.medworm.com/index.php?rid=948113&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.2.5.485%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , Oct 2007, Vol. 2, No. 5, Pages 485-488. (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=948113</comments>
            <pubDate>Fri, 12 Oct 2007 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">948113</guid>        </item>
        <item>
            <title>Does coffee raise cholesterol?</title>
            <link>http://www.medworm.com/index.php?rid=928211&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.2.4.373%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , Aug 2007, Vol. 2, No. 4, Pages 373-377. (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=928211</comments>
            <pubDate>Fri, 07 Sep 2007 03:06:04 +0100</pubDate>
            <guid isPermaLink="false">928211</guid>        </item>
        <item>
            <title>Cyclooxygenase-2 regulation of brain lipid composition</title>
            <link>http://www.medworm.com/index.php?rid=928216&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.2.4.399%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>This study investigated for the first time the effects of life-long absence of ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=928216</comments>
            <pubDate>Wed, 01 Aug 2007 09:16:00 +0100</pubDate>
            <guid isPermaLink="false">928216</guid>        </item>
        <item>
            <title>Antisense apolipoprotein B-100 as novel treatment for hypercholesterolemia: focus on ISIS 301012</title>
            <link>http://www.medworm.com/index.php?rid=928214&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.2.4.387%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , Aug 2007, Vol. 2, No. 4, Pages 387-393. 
		
	 Antisense oligonucleotides (ASOs) are single-stranded DNA-like molecules, which can effectively limit the availability of specific mRNA, resulting in less translation of the encoded protein. Since these antisense drugs largely distribute to hepatic cells,... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=928214</comments>
            <pubDate>Wed, 01 Aug 2007 09:15:58 +0100</pubDate>
            <guid isPermaLink="false">928214</guid>        </item>
        <item>
            <title>Nanocapsules: a novel formulation technology for platinum-based anticancer drugs</title>
            <link>http://www.medworm.com/index.php?rid=928220&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.2.4.445%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , Aug 2007, Vol. 2, No. 4, Pages 445-453. 
		
	 Platinum-based anticancer agents have been in widespread use for many years to successfully treat many different types of cancer. However, the efficacy of these drugs is limited by serious side effects. One of the strategies to reduce the side effects is ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=928220</comments>
            <pubDate>Wed, 01 Aug 2007 09:15:56 +0100</pubDate>
            <guid isPermaLink="false">928220</guid>        </item>
        <item>
            <title>Cholesterol-lowering drugs and Alzheimer’s disease</title>
            <link>http://www.medworm.com/index.php?rid=928218&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.2.4.423%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , Aug 2007, Vol. 2, No. 4, Pages 423-432. 
		
	 Experimental in vitro and in vivo findings as well as some retrospective epidemiological studies link cholesterol homeostasis with Alzheimer’s disease (AD), and there are some reports suggesting that statins may be efficacious in preventing or treating ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=928218</comments>
            <pubDate>Wed, 01 Aug 2007 09:15:54 +0100</pubDate>
            <guid isPermaLink="false">928218</guid>        </item>
        <item>
            <title>Role of lipids in brain injury and diseases</title>
            <link>http://www.medworm.com/index.php?rid=928217&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.2.4.403%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , Aug 2007, Vol. 2, No. 4, Pages 403-422. 
		
	 Lipid metabolism in CNS is of particular interest because of the high concentration of lipids. The importance of lipids in cell signaling and tissue physiology is demonstrated by many CNS disorders and injuries that involve deregulated metabolism. The ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=928217</comments>
            <pubDate>Wed, 01 Aug 2007 09:15:52 +0100</pubDate>
            <guid isPermaLink="false">928217</guid>        </item>
        <item>
            <title>Statins and early clinical outcome after coronary artery bypass grafting</title>
            <link>http://www.medworm.com/index.php?rid=928215&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.2.4.395%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , Aug 2007, Vol. 2, No. 4, Pages 395-398. 
		
	 Evaluation of: Powell BD, Bybee KA, Valeti I et al.: Influence of preoperative lipid-lowering therapy on post-operative outcome in patients undergoing coronary artery bypass grafting. Am. J. Cardiol. 99, 785–789 (2007). Lipid-lowering therapy with ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=928215</comments>
            <pubDate>Wed, 01 Aug 2007 09:15:51 +0100</pubDate>
            <guid isPermaLink="false">928215</guid>        </item>
        <item>
            <title>Heritability and genetics of lipid metabolism</title>
            <link>http://www.medworm.com/index.php?rid=928219&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.2.4.433%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , Aug 2007, Vol. 2, No. 4, Pages 433-444. 
		
	 In this article, the concept of heritability and genetic effect will be reviewed and our current knowledge of the genetics of lipid metabolism summarized. The concepts of polygenic conditions and epistasis are discussed at length, and an effort is made ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=928219</comments>
            <pubDate>Wed, 01 Aug 2007 09:15:50 +0100</pubDate>
            <guid isPermaLink="false">928219</guid>        </item>
        <item>
            <title>Lipid-induced β-cell dysfunction and oxidative stress</title>
            <link>http://www.medworm.com/index.php?rid=928221&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.2.4.455%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , Aug 2007, Vol. 2, No. 4, Pages 455-463. 
		
	 Type 2 diabetes is characterized by both insulin resistance and defective insulin secretion. Obesity is the major predisposing factor for Type 2 diabetes and is associated with excessive release of fatty acids from the expanded adipose tissue, leading to ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=928221</comments>
            <pubDate>Wed, 01 Aug 2007 09:15:49 +0100</pubDate>
            <guid isPermaLink="false">928221</guid>        </item>
        <item>
            <title>Long-chain acyl-CoA synthetases and fatty acid channeling</title>
            <link>http://www.medworm.com/index.php?rid=928222&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.2.4.465%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , Aug 2007, Vol. 2, No. 4, Pages 465-476. 
		
	 Thirteen homologous proteins comprise the long-chain acyl-CoA synthetase (ACSL), fatty acid transport protein (FATP), and bubblegum (ACSBG) subfamilies that activate long-chain and very-long-chain fatty acids to form acyl-CoAs. Gain- and loss-of-function ... (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=928222</comments>
            <pubDate>Wed, 01 Aug 2007 09:15:48 +0100</pubDate>
            <guid isPermaLink="false">928222</guid>        </item>
        <item>
            <title>Brown fat ‘master switch’ could lead to new obesity treatments</title>
            <link>http://www.medworm.com/index.php?rid=928213&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.2.4.383%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , Aug 2007, Vol. 2, No. 4, Pages 383-385. (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=928213</comments>
            <pubDate>Wed, 01 Aug 2007 09:15:47 +0100</pubDate>
            <guid isPermaLink="false">928213</guid>        </item>
        <item>
            <title>Dual action of the ezetimibe target Niemann-Pick C1-Like 1</title>
            <link>http://www.medworm.com/index.php?rid=928212&amp;cid=s_36443_162_f&amp;fid=36443&amp;url=http%3A%2F%2Fwww.futuremedicine.com%2Fdoi%2Fabs%2F10.2217%2F17460875.2.4.379%3Fai%3Dsi%26mi%3D2yyy%26af%3DR</link>
            <description>Future Lipidology , Aug 2007, Vol. 2, No. 4, Pages 379-382. (Source: Future Lipidology)</description>
            <author>Future Lipidology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=928212</comments>
            <pubDate>Wed, 01 Aug 2007 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">928212</guid>        </item>
    </channel>
</rss>
